Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Thymus-specific serine protease (PRSS16, TSSP) is an enzyme encoded by the PRSS16 gene, expressed exclusively in cortical thymic epithelial cells. It is involved in the processing of peptide antigens during positive selection of T-cells, possibly by editing C-terminal residues of peptides presented by MHC class II molecules, thereby influencing T-cell repertoire. The gene is located near the MHC Class I region on chromosome 6, a locus implicated in susceptibility to autoimmune diseases such as type 1 diabetes. However, knockout models indicate that loss of PRSS16 does not impact overall T-cell development or MHC class II surface expression, suggesting its functional role may be subtle and context-dependent, affecting specific peptide antigen editing and T-cell subsets.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Thymus-specific serine protease (PRSS16).